PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.14%
Negative revenue growth while PUK stands at 27.93%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.14%
Negative gross profit growth while PUK is at 27.93%. Joel Greenblatt would examine cost competitiveness or demand decline.
133.30%
EBIT growth 50-75% of PUK's 246.79%. Martin Whitman would suspect suboptimal resource allocation.
133.30%
Operating income growth above 1.5x PUK's 27.93%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-64.95%
Negative net income growth while PUK stands at 2157.71%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
152.19%
Positive 10Y revenue/share CAGR while PUK is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
40.64%
Positive 5Y CAGR while PUK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
2.58%
Positive 3Y CAGR while PUK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
133.20%
Net income/share CAGR at 50-75% of PUK's 202.69%. Martin Whitman might question if the firm’s product or cost base lags behind.
16.60%
Below 50% of PUK's 835.13%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-44.48%
Negative 3Y CAGR while PUK is 48.42%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.